Finding the best prices at pharmacies near you...

  1. Drug Classes
  2. Protein Kinase Inhibitors

Protein Kinase Inhibitors

Protein kinase inhibitors are used in targeted therapy to treat a range of cancers, such as leukemia, lung cancer, renal cancer, melanoma, breast cancer and thyroid cancer. They stop cancer cell growth and prevent further spreading of cancer by inhibiting the enzyme BCR-ABL tyrosine kinase. Commonly prescribed protein kinase inhibitors include Cabometyx (cabozantinib), Sprycel (dasatinib), and Gleevec (imatinib).

Drugs classified as Protein Kinase Inhibitors are frequently used to treat the following conditions:

Click on a drug below in order to find information and discounted prices at pharmacies near you.


Photo of the drug Cabometyx. Cabometyx
Protein Kinase Inhibitors
Commonly used to treat Renal Cancer.
Photo of the drug Iressa. Iressa
Protein Kinase Inhibitors
Commonly used to treat non-small cell lung cancer (NSCLC).
Photo of the drug Gleevec. Gleevec
Protein Kinase Inhibitors
Commonly used to treat Leukemia, GIST, Mastocytosis, acute lymphocytic leukemia (ALL), systemic mastocytosis, chronic eosinophilic leukemia (CEL).
Photo of the drug Tarceva. Tarceva
Protein Kinase Inhibitors
Commonly used to treat Pancreatic Cancer.
Photo of the drug Calquence. Calquence
Protein Kinase Inhibitors
Commonly used to treat non-Hodgkin's lymphoma (NHL).
Photo of the drug Caprelsa. Caprelsa
Protein Kinase Inhibitors
Commonly used to treat thyroid cancer.
Photo of the drug Tykerb. Tykerb
Protein Kinase Inhibitors
Commonly used to treat Breast Cancer.
Photo of the drug Sutent. Sutent
Protein Kinase Inhibitors
Commonly used to treat GIST, Pancreatic Cancer, Renal Cancer, gastrointestinal stromal tumors (GIST).
Photo of the drug Zydelig. Zydelig
Protein Kinase Inhibitors
Commonly used to treat chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma (NHL).
Photo of the drug Jakafi. Jakafi
Protein Kinase Inhibitors
Commonly used to treat myelofibrosis.
Photo of the drug Zelboraf. Zelboraf
Protein Kinase Inhibitors
Commonly used to treat malignant melanoma.
Photo of the drug Imbruvica. Imbruvica
Protein Kinase Inhibitors
Commonly used to treat chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma (NHL).
Photo of the drug Sprycel. Sprycel
Protein Kinase Inhibitors
Commonly used to treat acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML).
Photo of the drug Cotellic. Cotellic
Protein Kinase Inhibitors
Commonly used to treat malignant melanoma.
Photo of the drug Iclusig. Iclusig
Protein Kinase Inhibitors
Commonly used to treat acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML).
Photo of the drug Nerlynx. Nerlynx
Protein Kinase Inhibitors
Photo of the drug Zykadia. Zykadia
Protein Kinase Inhibitors
Commonly used to treat non-small cell lung cancer (NSCLC).
Photo of the drug Imatinib Mesylate. Imatinib Mesylate
Protein Kinase Inhibitors
Photo of the drug Kisqali Femara. Kisqali Femara
Protein Kinase Inhibitors
Commonly used to treat Breast Cancer.
Photo of the drug Vandetanib. Vandetanib
Protein Kinase Inhibitors

Share ModRN Health and Earn Rewards!

Login or Register to Share!


Sign In
Sign up for ModRN Health


For every friend or family member you refer you will earn 100 Reward Points on their first prescription purchase! Plus you earn Reward Points on every prescription purchase they make with their ModRN Health card.

You may share without logging in or registering, but please note you will not receive any reward points.